LucidQuest

@UC5FppXttvkm2c8AjX3fr1BA - 309 subscribers

ACCELERATE YOUR SUCCESS with LUCIDQUEST STRATEGIC and TACTICAL COMPETITIVE INSIGHTS Improve Competitiveness, Differentiate and Win in the Pharma, Biotech and Healthcare Spaces We empower our clients to craft winning strategies and address critical business challenges, by leveraging our deep commercial and scientific expertise, augmented with evidence-based insights, strategy-enabling tech and an innovative consulting approach. We cover all major therapy areas, including cell and gene therapy, rare diseases and vaccines. DIGITAL HEALTH, ARTIFICIAL INTELLIGENCE and INTERNET of EVERYTHING Accelerate Innovation with Strategic Consulting in Emerging Tech We bridge healthcare/pharma/biotech and emerging tech, accelerating innovation through consulting and pioneering product development. Get in touch: [email protected] or www.lqventures.com/ Thank you!

Home Videos Live Playlists

Oncology Update–16 Feb 2026: KEYTRUDA FDA Ovarian Approval, Imfinzi EU CHMP Backing and More

Oncology Update–16 Feb 2026: KEYTRUDA FDA Ovarian Approval, Imfinzi EU CHMP Backing and More LucidQuest

4 views - 23 hours ago

Public Health Update – 13 February 2026: 37% of Cancers Preventable, LDL Cut 60% and More

Public Health Update – 13 February 2026: 37% of Cancers Preventable, LDL Cut 60% and More LucidQuest

24 views - 3 days ago

Rare Disease Update – 12 February 2026: Venglustat GD3 win, RGX-121 CRL and More

Rare Disease Update – 12 February 2026: Venglustat GD3 win, RGX-121 CRL and More LucidQuest

11 views - 4 days ago

Cardiovascular Update – 12 Feb 2026: OCEANIC-STROKE results, new AIS guideline and more

Cardiovascular Update – 12 Feb 2026: OCEANIC-STROKE results, new AIS guideline and more LucidQuest

10 views - 4 days ago

H2 2025 Health Mobile Apps Landscape

H2 2025 Health Mobile Apps Landscape LucidQuest

7 views - 4 days ago

Immunology Update – 11 Feb 2026: EU Gastric Periop IO, China UC S1P and More

Immunology Update – 11 Feb 2026: EU Gastric Periop IO, China UC S1P and More LucidQuest

5 views - 5 days ago

Endocrinology Update – 10 Feb 2026: China OKs Xianyida, CagriSema Tops Ozempic and More

Endocrinology Update – 10 Feb 2026: China OKs Xianyida, CagriSema Tops Ozempic and More LucidQuest

7 views - 6 days ago

ARTIFICIAL INTELLIGENCE and DIGITAL HEALTH Update – Feb 9, 2026: CardioMEMS, Samsung Health & More

ARTIFICIAL INTELLIGENCE and DIGITAL HEALTH Update – Feb 9, 2026: CardioMEMS, Samsung Health & More LucidQuest

8 views - 1 week ago

Hematology Update – 09 Feb 2026: D-VRd FDA OK, HYMPAVZI Priority Review and More

Hematology Update – 09 Feb 2026: D-VRd FDA OK, HYMPAVZI Priority Review and More LucidQuest

16 views - 1 week ago

Respiratory Update – 06 Feb 2026: China OKs Trelegy for Asthma, Ensifentrine NDA and More

Respiratory Update – 06 Feb 2026: China OKs Trelegy for Asthma, Ensifentrine NDA and More LucidQuest

9 views - 1 week ago

Vaccines Research Update – 06 Feb 2026: EU Approves Arexvy 18+, Brazil IXCHIQ Pilot and More

Vaccines Research Update – 06 Feb 2026: EU Approves Arexvy 18+, Brazil IXCHIQ Pilot and More LucidQuest

19 views - 1 week ago

Gene & Cell Therapy Update – 5 Feb 2026: CAR-T Breakthrough Designation, Glioblastoma CAR-NK & More

Gene & Cell Therapy Update – 5 Feb 2026: CAR-T Breakthrough Designation, Glioblastoma CAR-NK & More LucidQuest

14 views - 1 week ago

Womens Health Update – 4 Feb 2026: FDA Review for TNBC Treatment, OTC Contraceptive in Japan & More

Womens Health Update – 4 Feb 2026: FDA Review for TNBC Treatment, OTC Contraceptive in Japan & More LucidQuest

5 views - 1 week ago

Neuroscience Update – 4 Feb 2026: Ph 2 Study in Tardive Dyskinesia, Ph 3 Results for Gaucher & More

Neuroscience Update – 4 Feb 2026: Ph 2 Study in Tardive Dyskinesia, Ph 3 Results for Gaucher & More LucidQuest

10 views - 1 week ago

Obesity Update – 03 Feb 2026: CT-388 Phase 2 Data, Monthly Portfolio Deal and More

Obesity Update – 03 Feb 2026: CT-388 Phase 2 Data, Monthly Portfolio Deal and More LucidQuest

10 views - 1 week ago

Oncology Update – 02 Feb 2026: ENHERTU China 2L Gastric Approval, AKEEGA CHMP Opinion and More

Oncology Update – 02 Feb 2026: ENHERTU China 2L Gastric Approval, AKEEGA CHMP Opinion and More LucidQuest

16 views - 2 weeks ago

Public Health Update – Jan 29, 2026: Breast Cancer Blood Test, Exercise Benefits, BPA Risks and More

Public Health Update – Jan 29, 2026: Breast Cancer Blood Test, Exercise Benefits, BPA Risks and More LucidQuest

6 views - 2 weeks ago

Cardiovascular Update – 29 Jan 2026: Canada OKs Oral GLP-1 for CV Risk, Evolocumab Cuts MACE & More

Cardiovascular Update – 29 Jan 2026: Canada OKs Oral GLP-1 for CV Risk, Evolocumab Cuts MACE & More LucidQuest

26 views - 2 weeks ago

Rare Diseases Update – 29 Jan 2026: EU approves C3G treatment, FDA Orphan Designation for MF & More

Rare Diseases Update – 29 Jan 2026: EU approves C3G treatment, FDA Orphan Designation for MF & More LucidQuest

20 views - 2 weeks ago

Immunology Update – 28 Jan 2026: Novartis’ ianalumab Breakthrough, Sobi’s Aspaveli Approval and More

Immunology Update – 28 Jan 2026: Novartis’ ianalumab Breakthrough, Sobi’s Aspaveli Approval and More LucidQuest

28 views - 2 weeks ago

Endocrinology Update – 27 January, 2026: EU OKs T1D delay therapy, US denosumab biosimilars and more

Endocrinology Update – 27 January, 2026: EU OKs T1D delay therapy, US denosumab biosimilars and more LucidQuest

10 views - 3 weeks ago

ARTIFICIAL INTELLIGENCE and DIGITAL HEALTH Update – January 26, 2026: ARPA-H Cardio Agents and More

ARTIFICIAL INTELLIGENCE and DIGITAL HEALTH Update – January 26, 2026: ARPA-H Cardio Agents and More LucidQuest

17 views - 3 weeks ago

Hematology Update – 26 Januray, 2026: Epcoritamab PFS in DLBCL, FDA MRD/CR Draft and More

Hematology Update – 26 Januray, 2026: Epcoritamab PFS in DLBCL, FDA MRD/CR Draft and More LucidQuest

14 views - 3 weeks ago

Respiratory Update – 23 January, 2026: Krystal Biotech CFTR, Kinaset’s $103M for Asthma and more

Respiratory Update – 23 January, 2026: Krystal Biotech CFTR, Kinaset’s $103M for Asthma and more LucidQuest

17 views - 3 weeks ago

Vaccines Research Update – 23 January 2026: PanChol Cholera Vaccine, Clover RSV Vaccine and More

Vaccines Research Update – 23 January 2026: PanChol Cholera Vaccine, Clover RSV Vaccine and More LucidQuest

14 views - 3 weeks ago

Gene Therapy Update – 22 Jan 2026: FDA Eases Regulations, AstraZeneca Secures CAR-T Rights and More

Gene Therapy Update – 22 Jan 2026: FDA Eases Regulations, AstraZeneca Secures CAR-T Rights and More LucidQuest

77 views - 3 weeks ago

Neuroscience Update – 21 Jan, 2026: Brain-Shuttle Alzheimer’s Deal, Alpha-Mannosidosis OK and More

Neuroscience Update – 21 Jan, 2026: Brain-Shuttle Alzheimer’s Deal, Alpha-Mannosidosis OK and More LucidQuest

26 views - 3 weeks ago

Women's Health Update – 21 January, 2026: First US Menkes Tx, Nexplanon 5Y and More

Women's Health Update – 21 January, 2026: First US Menkes Tx, Nexplanon 5Y and More LucidQuest

11 views - 3 weeks ago

Obesity Update – January 20, 2026: Orforglipron FDA Path, $1.3bn Discovery Deal and More

Obesity Update – January 20, 2026: Orforglipron FDA Path, $1.3bn Discovery Deal and More LucidQuest

19 views - 3 weeks ago

Oncology Update – January 19, 2026: BLA Filed for EGFRm NSCLC, NDA Accepted for TGCT and More

Oncology Update – January 19, 2026: BLA Filed for EGFRm NSCLC, NDA Accepted for TGCT and More LucidQuest

14 views - 4 weeks ago

Public Health Update – January 16, 2026: Cartilage Regeneration, GLP-1 Weight Regain and More

Public Health Update – January 16, 2026: Cartilage Regeneration, GLP-1 Weight Regain and More LucidQuest

24 views - 1 month ago

Cardiovasculary Update – January 15, 2026: TMVR approved, Aficamten cleared, Robotic EP and more

Cardiovasculary Update – January 15, 2026: TMVR approved, Aficamten cleared, Robotic EP and more LucidQuest

23 views - 1 month ago

Rare Diseases Update – January 15, 2026: FDA OKs ZYCUBO, EU OKs Wayrilz, Elfabrio Canada and More

Rare Diseases Update – January 15, 2026: FDA OKs ZYCUBO, EU OKs Wayrilz, Elfabrio Canada and More LucidQuest

12 views - 1 month ago

Immunology Update – January 14, 2026: Wayrilz ITP approval, Tremfya pedi OK, Saphnelo pen and More

Immunology Update – January 14, 2026: Wayrilz ITP approval, Tremfya pedi OK, Saphnelo pen and More LucidQuest

18 views - 1 month ago

Endocrinology Update – January 13, 2026: Hip Bone Density Marker, Oral PTH, EU Denosumab and More

Endocrinology Update – January 13, 2026: Hip Bone Density Marker, Oral PTH, EU Denosumab and More LucidQuest

21 views - 1 month ago

ARTIFICIAL INTELLIGENCE and DIGITAL HEALTH Update – January 12, 2026: OpenAI for Healthcare and More

ARTIFICIAL INTELLIGENCE and DIGITAL HEALTH Update – January 12, 2026: OpenAI for Healthcare and More LucidQuest

33 views - 1 month ago

Hematology Update – January 12, 2026: Chemo-free FL, Lunsumio SC 1-min, sonrotoclax China and More

Hematology Update – January 12, 2026: Chemo-free FL, Lunsumio SC 1-min, sonrotoclax China and More LucidQuest

28 views - 1 month ago

Vaccines Update – January 9, 2026: CEPI backs H5 Phase 3, Sanofi buys Dynavax, RSV data and More

Vaccines Update – January 9, 2026: CEPI backs H5 Phase 3, Sanofi buys Dynavax, RSV data and More LucidQuest

19 views - 1 month ago

Respiratory Update – January 9, 2026: PPF FDA Nod, Japan Asthma, GSK Access and More

Respiratory Update – January 9, 2026: PPF FDA Nod, Japan Asthma, GSK Access and More LucidQuest

28 views - 1 month ago

Gene & Cell Therapy Update – January 8, 2026: ITVISMA SMA Breakthrough, Yartemlea Approval and More

Gene & Cell Therapy Update – January 8, 2026: ITVISMA SMA Breakthrough, Yartemlea Approval and More LucidQuest

44 views - 1 month ago

Women’s Health Update – January 7, 2026: AI heart failure screening, new HER2 therapy and More

Women’s Health Update – January 7, 2026: AI heart failure screening, new HER2 therapy and More LucidQuest

14 views - 1 month ago

Neuroscience Update – January 7, 2026: Natalizumab access, Tyruko US launch, AXS-05 review and more

Neuroscience Update – January 7, 2026: Natalizumab access, Tyruko US launch, AXS-05 review and more LucidQuest

23 views - 1 month ago

Obesity Update – January 5, 2026: Oral Wegovy OK, Retatrutide Win, CagriSema Filing and More

Obesity Update – January 5, 2026: Oral Wegovy OK, Retatrutide Win, CagriSema Filing and More LucidQuest

23 views - 1 month ago

Oncology Update – January 5, 2026: Faster Rybrevant, HER2 Combo Win, TNBC Filing and More

Oncology Update – January 5, 2026: Faster Rybrevant, HER2 Combo Win, TNBC Filing and More LucidQuest

34 views - 1 month ago

Public Health Update – December 19, 2025: Vaccine Safety, Cancer–Nerve Links, Immune Aging and More

Public Health Update – December 19, 2025: Vaccine Safety, Cancer–Nerve Links, Immune Aging and More LucidQuest

10 views - 1 month ago

Rare Diseases Update – December 17, 2025: FDA Approves Ianalumab, Waskyra Gene Therapy and More

Rare Diseases Update – December 17, 2025: FDA Approves Ianalumab, Waskyra Gene Therapy and More LucidQuest

27 views - 1 month ago

Cardiovascular Update – December 17, 2025: TVNS Rehab, Lerodalcibep OK, Cardamyst PSVT and More

Cardiovascular Update – December 17, 2025: TVNS Rehab, Lerodalcibep OK, Cardamyst PSVT and More LucidQuest

16 views - 1 month ago

Immunology Update – December 17, 2025: ITP win, CAR T in SLE, First RDEB gene therapy and More

Immunology Update – December 17, 2025: ITP win, CAR T in SLE, First RDEB gene therapy and More LucidQuest

16 views - 1 month ago

ARTIFICIAL INTELLIGENCE and DIGITAL HEALTH Update – December 16, 2025: AI Chatbot Risks and More

ARTIFICIAL INTELLIGENCE and DIGITAL HEALTH Update – December 16, 2025: AI Chatbot Risks and More LucidQuest

13 views - 1 month ago

Endocrinology Update – December 16, 2025: Mounjaro China, Wegovy 7.2 mg backed, Libre 3 alert & More

Endocrinology Update – December 16, 2025: Mounjaro China, Wegovy 7.2 mg backed, Libre 3 alert & More LucidQuest

24 views - 2 months ago

Hematology Update – December 15, 2025: BTK H2H, cHL priority review, Sanofi rare-heme wins and More

Hematology Update – December 15, 2025: BTK H2H, cHL priority review, Sanofi rare-heme wins and More LucidQuest

16 views - 2 months ago

Vaccines Update – December 12, 2025: Per-C-Vax review, MAV/06 interchange, VAX-31 Phase 3 and More

Vaccines Update – December 12, 2025: Per-C-Vax review, MAV/06 interchange, VAX-31 Phase 3 and More LucidQuest

13 views - 2 months ago

Respiratory Update – December 12, 2025: Beyfortus Launch, AATD Gene Edit, OMLYCLO Update

Respiratory Update – December 12, 2025: Beyfortus Launch, AATD Gene Edit, OMLYCLO Update LucidQuest

20 views - 2 months ago

Gene & Cell Therapy Update – December 11, 2025: Imvax OS Data, FDA Approvals for Breyanzi and More

Gene & Cell Therapy Update – December 11, 2025: Imvax OS Data, FDA Approvals for Breyanzi and More LucidQuest

21 views - 2 months ago

Women’s Health Update – December 10, 2025: Migraine Treatment Progress, Dementia Advances and More

Women’s Health Update – December 10, 2025: Migraine Treatment Progress, Dementia Advances and More LucidQuest

9 views - 2 months ago

Neuroscience Update – December 10, 2025: Atogepant Migraine Data, LNK01006 FDA Approval and More

Neuroscience Update – December 10, 2025: Atogepant Migraine Data, LNK01006 FDA Approval and More LucidQuest

16 views - 2 months ago

Obesity Update – December 9, 2025: Bofanglutide Ph 3, Amycretin Success, Mazdutide Filing and More

Obesity Update – December 9, 2025: Bofanglutide Ph 3, Amycretin Success, Mazdutide Filing and More LucidQuest

16 views - 2 months ago

Oncology Update – December 8, 2025: Fast-Track ADC, Imfinzi for Surgery, Cancer Blood Test and More

Oncology Update – December 8, 2025: Fast-Track ADC, Imfinzi for Surgery, Cancer Blood Test and More LucidQuest

11 views - 2 months ago

Public Health Update – December 5, 2025: Asthma Breakthroughs, mRNA Anti-Infectives and More

Public Health Update – December 5, 2025: Asthma Breakthroughs, mRNA Anti-Infectives and More LucidQuest

13 views - 2 months ago

Cardiovascular Update – December 4, 2025: WINREVAIR PVR win, Baxdrostat Priority Review and More

Cardiovascular Update – December 4, 2025: WINREVAIR PVR win, Baxdrostat Priority Review and More LucidQuest

32 views - 2 months ago